bioLytical Laboratories Inc. Announces Launch of its INSTI® HCV Antibody Test for Professional Use in Australia
May 19, 2024 18:00 ET
|
bioLytical Laboratories Inc.
bioLytical launches the INSTI® HCV Antibody Test in Australia with its inclusion on the Australian Register of Therapeutic Goods (ARTG number: 448926)
Hepatitis C Virus Testing Market Poised to Expand at a 5.8% CAGR, Surpassing US$1,185.2 Million by 2030 | Persistence Market Research
January 19, 2024 03:30 ET
|
Persistence Market Research
New York, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Market Overview: The Hepatitis C Virus (HCV) Testing Market is a dynamic and evolving sector within the healthcare industry, driven by the persistent...